ALT-2074
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ALT-2074, covering 2008-07-02 to 2008-07-02. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of ALT-2074 in Subjects With Type-2 Diabetes, Haptoglobin Type 2-2 Genotype and Coronary Artery Disease [Phase 2]